INSIGHTS ON CONTRACT PHARMA MANUFACTURING

• Quality By Design For Outsourced Operations

  A practical guide to applying Quality by Design to outsourced GXP operations, helping virtual and hybrid sponsors maintain regulatory control, inspection readiness, and accountability.

• The Biosimilar Market Reality: Expansion, Risk, And Consolidation

  An executive view on how biosimilar misconceptions around demand, risk, and cost drove market crowding, manufacturing pressure, and eventual consolidation across the industry.

• OneTeam™: Setting A New Standard for Biotech Program Visibility

  An on‑demand session showing how integrated governance and real‑time data boost visibility, collaboration, and control in outsourced gene therapy development.

• Less Risk, More Speed -The New Blueprint For Bioconjugate Development

  A fireside chat on how integrated development models reduce risk and accelerate bioconjugate timelines from discovery through GMP manufacturing.

• The Future Of Sustainable Amorphous Dispersion Development

  Sustainable amorphous dispersion cuts cost, risk, and timelines by removing solvent waste, simplifying manufacturing, strengthening supply chains, and scaling efficiently to commercialization.

• Formulating The Future: A Practical Guide To Nucleic Acid Therapeutics

  An expert-led webinar exploring nucleic acid therapeutic modalities, delivery systems, formulation challenges, and real-world case studies shaping drug product development.

• Understanding And Implementing USP <665> For Single-Use Systems

  New expectations for single-use systems require structured risk assessment and extractables testing. As compliance deadlines near, practical guidance aligns science, knowledge, regulatory readiness.

• 6 Strategic Pillars For Selecting A Drug Packaging Partner

  Early engagement with an expert packaging partner supports safe, cost-effective drug development and logistical success from precommercial stages through full market launch.

• The Future Of Pharma Packaging Trends, Technologies, And Patient-Centric Solutions

  Pharmaceutical packaging must evolve alongside drug development to ensure stability, safety, and regulatory adherence, utilizing innovative designs to improve therapeutic outcomes and patient accessibility.

• Inside Asymchem's Technology-Led Expansion Of Oligonucleotide Capabilities

  Advances in synthesis, enzymatic ligation, and purification are reshaping oligonucleotide manufacturing, improving scalability, sustainability, and complexity from research to production.